Item 9.01. Financial Statements and Exhibits.
(a) Financial Statements of Business Acquired
The historical audited balance sheets of GeneSiC as of December 31, 2021 and 2020 and the related audited statements of operations, stockholders’ equity, and cash flows for the years then ended, and the related notes thereto, and the independent auditor’s report, are filed as Exhibit 99.1 to this Form 8-K.
The unaudited condensed balance sheets of GeneSiC as of June 30, 2022 and December 31, 2021 and the related unaudited statements of operations, stockholders’ equity, and cash flows for the six months ended June 30, 2022, and the related notes thereto are filed as Exhibit 99.2 to this Form 8-K.
(b) Pro Forma Financial Information
The following unaudited pro forma financial information for the Company is filed as Exhibit 99.3 to this Form 8‑K:
•Unaudited Pro Forma Condensed Combined Balance Sheet as of June 30, 2022;
•Unaudited Pro Forma Condensed Combined Statement of Operations for the six months ended June 30, 2022;
•Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2021; and
•Notes to the Unaudited Pro Forma Condensed Combined Financial Statements.
The following unaudited pro forma financial information for the Company is filed as Exhibit 99.4 to this Form 8‑K:
•Unaudited Pro Forma Condensed Combined Statement of Operations for the year ended December 31, 2022; and
•Notes to the Unaudited Pro Forma Condensed Combined Financial Statements.
Cautionary Language Concerning Forward-Looking Statements
The pro forma financial information in Exhibit 99.2 contains forward looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial progress and future financial performance of the Company as well as the Acquisition. This pro forma financial information contains forward-looking statements that are based upon management’s current expectations, assumptions, estimates, projections and beliefs. These statements include, but are not limited to, statements regarding our current product offerings and marketing efforts, and the financial impact of the Acquisition. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by these forward-looking statements. Other risks relating to the Company’s business, including risks that could cause results to differ materially from those projected in such forward-looking statements, are provided in the Company’s annual report on Form 10-K for the year ended December 31, 2022, subsequent quarterly reports on Form 10-Q, especially under the heading “Risk Factors.” The forward-looking statements in this Form 8-K/A speak only as of this date, and the Company disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.
(d) Exhibits
The following exhibits are filed as part of this Form 8-K:
| | | | | |
Exhibit Number | Description |
23.1* | |
99.1* | |
99.2* | |
99.3* | |
99.4+ | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
* Previously filed as part of amendment no. 1 on Form 8-K/A, filed with the SEC on October 31, 2022.
+ Filed herewith.